Format

Send to

Choose Destination
J Control Release. 2016 May 10;229:120-129. doi: 10.1016/j.jconrel.2016.03.029. Epub 2016 Mar 19.

Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.

Author information

1
Wayne State University, Detroit, MI, United States.
2
Wayne State University, Detroit, MI, United States; Karmanos Cancer Institute, Detroit, MI, United States.
3
Philipps-Universität Marburg, Marburg, Germany.
4
Wayne State University, Detroit, MI, United States; Karmanos Cancer Institute, Detroit, MI, United States; Ludwig-Maximilians Universität München, Munich, Germany. Electronic address: Olivia.merkel@LMU.de.

Abstract

Asthma is a worldwide health problem. Activated T cells (ATCs) in the lung, particularly T helper 2 cells (Th2), are strongly associated with inducing airway inflammatory responses and chemoattraction of inflammatory cells in asthma. Small interfering RNA (siRNA) as a promising anti-sense molecule can specifically silence inflammation related genes in ATCs, however, lack of safe and efficient siRNA delivery systems limits the application of siRNA as a therapeutic molecule in asthma. Here, we designed a novel pulmonary delivery system of siRNA, transferrin-polyethylenimine (Tf-PEI), to selectively deliver siRNA to ATCs in the lung. Tf-PEI polyplexes demonstrated optimal physicochemical properties such as size, distribution, zeta-potential, and siRNA condensation efficiency. Moreover, in vitro studies showed significantly enhanced cellular uptake and gene knockdown mediated by Tf-PEI polyplexes in human primary ATCs. Biodistribution of polyplexes in a murine asthmatic model confirmed that Tf-PEI polyplexes can efficiently and selectively deliver siRNA to ATCs. In conclusion, the present work proves the feasibility to target ATCs in asthma via Tf receptor. This strategy could potentially be used to design an efficient siRNA delivery system for asthma therapy.

KEYWORDS:

Asthma; Polyethylenimine (PEI); Pulmonary delivery; Transferrin; siRNA delivery

PMID:
27001893
PMCID:
PMC4886848
DOI:
10.1016/j.jconrel.2016.03.029
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center